HK$5.35
HK$-0.02 (-0.37%)
End-of-day quote: 05/16/2024
SEHK:1066

Shandong Weigao Group Medical Polymer Company Annual Report

Year Year 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005
Rev. Revenue
HK$13.62B HK$13.15B HK$11.35B HK$10.36B HK$8.81B HK$6.29B HK$5.62B HK$5.92B HK$5.28B HK$4.61B HK$3.69B HK$3.18B HK$2.46B HK$1.88B HK$1.51B HK$1.10B HK$786.93M HK$569.99M
GM % Gross Margin %
52.14% 55.14% 56.73% 62.52% 62.44% 63.43% 63.66% 59.40% 58.82% 59.11% 57.26% 55.34% 55.21% 53.30% 50.07% 45.68% 42.61% 41.10%
OM Operating Margin
21.86% 22.58% 20.58% 22.18% 20.48% 21.83% 19.68% 21.70% 21.30% 23.08% 23.17% 26.44% 24.21% 26.56% 27.22% 23.70% 20.36% 18.73%
EPS Earnings Per Share
HK$0.00 HK$0.56 HK$0.61 HK$0.54 HK$0.45 HK$0.43 HK$0.33 HK$0.30 HK$0.29 HK$0.26 HK$0.22 HK$0.21 HK$0.23 HK$0.22 HK$0.19 HK$0.15 HK$0.12 HK$0.08 HK$0.04 HK$0.03
Div. Dividends
HK$0.17 HK$0.14 HK$0.13 HK$0.11 HK$0.10 HK$0.09 HK$0.09 HK$0.08 HK$0.07 HK$0.06 HK$0.07 HK$0.06 HK$0.04 HK$0.04 HK$0.04 HK$0.02 HK$0.01 HK$0.01
PR % Payout Ratio %
27.87% 25.93% 28.89% 25.58% 30.30% 30.00% 31.03% 30.77% 31.82% 28.57% 30.43% 27.27% 21.05% 26.67% 33.33% 25.00% 25.00% 33.33%
Sha. Shares
4570.63m 4570.63m 4522.33m 4522.33m 4522.33m 4522.33m 4522.33m 4476.37m 4476.37m 4476.37m 4476.37m 4476.37m 4305.12m 4305.12m 4305.12m 3982.24m 3862.24m 3862.24m
OCF Operating Cash Flow
HK$2.21B HK$3.04B HK$2.70B HK$2.32B HK$2.22B HK$1.27B HK$1.05B HK$1.05B HK$711.22M HK$720.17M HK$806.03M HK$620.79M HK$523.51M HK$479.07M HK$437.48M HK$276.21M HK$176.55M HK$68.73M
FCF Free Cash Flow
HK$1.56B HK$1.93B HK$1.78B HK$1.38B HK$1.42B HK$-161.79M HK$432.04M HK$473.97M HK$114.06M HK$-36.00M HK$-238.51M HK$-514.84M HK$184.07M HK$160.67M HK$235.07M HK$50.66M HK$21.19M HK$-96.43M
FCFS Free Cash Flow Per Share
HK$0.24 HK$0.43 HK$0.39 HK$0.30 HK$0.32 HK$-0.04 HK$0.09 HK$-0.01 HK$-0.00 HK$-0.05 HK$-0.03 HK$-0.12 HK$0.04 HK$0.04 HK$0.06 HK$0.01 HK$0.01 HK$-0.03